By providing the conditions for efficient access to genetic resources, ABS policy offers the opportunity to promote the discovery of new bio-active compounds that contribute to the health of Canadians. For example, a drug developed by ABS pioneer Shaman Pharmaceuticals, is now being brought to final round of clinical trials. This drug may have a large impact on infant mortality in the developing world as it prevents diarrhoea through a new biological mechanism that avoids the side effects of current medicines 11. In a broader sense, the potential use of biological processes instead of petroleum products or high energy chemical ones will reduce our industry's environmental footprint, leading to a healthier environment for Canadians.
11Philipkoski, Kristen. (July 11, 2005). A Drug to Eradicate Diarrhea. See:
accessed July 18, 2005.